查看购物车
  • Traditional Chinese
  • English
中东和非洲 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户
市场调查报告书
商品编码
1562192

中东和非洲 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户

Middle East & Africa PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 131 Pages | 订单完成后即时交付

价格

中东和非洲PCR技术市场预计将从2022年的6.2635亿美元成长到2030年的10.5727亿美元。

遗传性疾病和传染病发病率的上升推动了中东和非洲 PCR 技术市场

根据国家组织关于遗传性疾病或先天性残疾的信息，遗传性疾病是一种罕见疾病，但每年总共有超过 15,500 例阳性诊断。美国 MJH 生命科学公司 2022 年发布的报告估计，全球每年约有 30 万名新生儿出生时患有镰状细胞疾病 (SCD)，约占全球人口的 5%。此外，根据诺华公司 2020 年 6 月的报告，SCD 影响全球约 800 万人。在非洲，每天约有 500 名儿童死于与 SCD 相关的併发症，该疾病的负担最重。由于 SCD 发病率不断上升，病理中心越来越多地采用数位聚合酶炼式反应 (dPCR)，其中该技术被用于针对各种 DNA 特异性序列来确认诊断并设计各种临床测试。 dPCR 可以只针对一个 DNA 分子中的特定 DNA 序列。该工具使研究人员能够检测使用即时 PCR 难以识别的罕见基因突变。 COVID-19 的爆发对 PCR 技术市场产生了重大影响。 PCR 是一种几乎无所不在、强大且可靠的技术，大多数分子生物学实验室都使用它来扩增特定的 DNA 片段，以进行基因分型、克隆和单核苷酸变异分析。扩增的 DNA 甚至可以作为大多数下一代定序 (NGS) 製备的基础。几乎所有诊断测试都使用即时 PCR 来测试有 COVID-19 症状的人。大多数生物技术和製药企业将重点转向研发 (R&D) 部门，寻找针对 COVID-19 的新化合物或治疗方法，这反过来又使 PCR 技术市场受益。 2022年2月，罗氏将新发表的分子实验室仪器Cobas 5800系统加入其COVID-19 PCR产品组合中，供接受CE认证的国家使用。这些产品包括 Cobas SARS-CoV-2 和甲型/乙型流感检测，以及 Cobas SARS-CoV-2 定性检测。本产品在低、中、高容量分子实验室测试中提供一致的性能和效率。因此，遗传性疾病和传染病发病率的增加支持了 PCR 技术市场的成长。

中东和非洲 PCR 技术市场概况

中东和非洲 PCR 技术市场分为沙乌地阿拉伯、阿联酋、南非以及中东和非洲其他地区。由于该地区各种试剂系统和自动化系统的开发增加、诊断实验室的各种新产品以及越来越多的会议、会议、工作坊和专题讨论会，预计该地区将出现显着增长。沙乌地阿拉伯是中东和非洲成长最快的国家之一。透过政府和国际参与者之间的公私合作伙伴关係改变医疗保健基础设施可以加强该国的医疗保健部门。这些伙伴关係和私有化努力与沙乌地阿拉伯政府转型国家经济的「2030 年愿景」政策一致。根据国际贸易管理局的数据，作为 2030 年愿景的一部分，沙乌地阿拉伯政府投资约 650 亿美元来建设该国的医疗保健基础设施。 PCR技术在传染病、肿瘤学、自体免疫疾病、遗传疾病、爱滋病毒/爱滋病等诊断方面有着广泛的应用。它由医院、实验室和其他医疗机构的医生以及患者治疗过程的各个阶段使用。此外，DNA 多态性、肺癌和大肠癌的研究使用 dPCR 和 qPCR 技术来评估基因的 mRNA 表达，推动了 PCR 技术市场的发展。沙乌地阿拉伯由于近亲结婚导致遗传疾病数量不断增加，婚前基因筛检的增加推动了市场的成长。沙乌地阿拉伯政府强制要求婚前进行婚前基因筛检，以检查基因相容性，以减少该国最受欢迎的遗传性血液疾病，如镰状细胞疾病和β地中海贫血。因此，沙乌地阿拉伯遗传病患病率的上升和婚前基因检测的增加推动了市场的成长。此外，不断增长的癌症病例也推动了沙乌地阿拉伯的癌症研究。根据 Globocan 2020资料，该国记录了约 27,885 例新癌症病例。研究发现，所有年龄层的癌症五年盛行率为每 10 万人 237.4 人，这反过来又推动了沙乌地阿拉伯对 PCR 技术的需求。

中东和非洲 PCR 技术市场收入及 2030 年预测（百万美元）

中东和非洲 PCR 技术市场细分

中东和非洲 PCR 技术市场分为技术、产品、应用、最终用户和国家。

根据技术，中东和非洲 PCR 技术市场分为即时 PCR、常规 PCR、逆转录、数位 PCR、多重 RTPCR、热启动 PCR 等。 2022 年，即时 PCR 领域在中东和非洲 PCR 技术市场中占据最大份额。

在产品方面，中东和非洲 PCR 技术市场分为试剂和耗材、仪器以及软体和服务。到2022年，试剂和耗材细分市场在中东和非洲PCR技术市场中占据最大份额。此外，西林瓶尺寸分为0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，仪器部分分为桌上型 PCR 和便携式热循环仪/PCR。

根据应用，中东和非洲 PCR 技术市场分为基因表现分析、基因定序、基因分型、核酸合成、标准验证、护理点诊断应用、环境应用等。 2022 年，基因表现分析领域在中东和非洲 PCR 技术市场中占据最大份额。

根据最终用户，中东和非洲 PCR 技术市场分为医院和诊断中心、製药和生物技术公司、学术机构和研究实验室等。 2022 年，医院和诊断中心细分市场在中东和非洲 PCR 技术市场中占据最大份额。

按国家/地区划分，中东和非洲 PCR 技术市场分为沙乌地阿拉伯、南非、阿联酋以及中东和非洲其他地区。 2022 年，沙乌地阿拉伯将主导中东和非洲 PCR 技术市场。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc 和 Ellume Ltd 是一些领先的营运公司中东和非洲PCR 技术市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：中东和非洲 PCR 技术市场 - 主要产业动态

  • PCR 技术市场 - 主要产业动态
  • 市场驱动因素
    • 遗传性疾病和传染病的盛行率不断上升
  • 市场限制
    • PCR 系统的高成本和替代检测的可用性
  • 市场机会
    • 新兴国家越来越多地采用 PCR 技术
    • POC 测试需求不断增加
  • 未来趋势
    • PCR 技术的进步
  • 驱动因素和限制的影响：

第 5 章：PCR 技术市场 - 中东和非洲市场分析

  • PCR 技术市场收入，2020 - 2030

第 6 章：中东和非洲 PCR 技术市场分析 - 按技术

  • 概述
  • 实时萤光定量PCR
  • 常规PCR
  • 逆转录聚合酶连锁反应
  • 数位PCR
  • 多重逆转录聚合酶连锁反应
  • 热启动PCR
  • 其他的

第 7 章：中东和非洲 PCR 技术市场分析 - 按产品

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按产品划分）（%）
  • 试剂及耗材
  • 仪器仪表
  • 软体和服务

第 8 章：中东和非洲 PCR 技术市场分析 - 按应用

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额，按应用划分 (%)
  • 基因表现分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 标准验证
  • 护理点诊断
  • 环境应用
  • 其他的

第 9 章：中东和非洲 PCR 技术市场分析 - 按最终用户

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按最终用户划分）（%）
  • 医院和诊断中心
  • 学术界及研究机构
  • 製药和生物技术公司
  • 其他的

第 10 章：中东和非洲 PCR 技术市场 - 国家分析

  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区

第 11 章：PCR 技术市场-产业格局

  • 概述
  • PCR 技术市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Ellume Ltd

第 13 章：附录

Product Code: BMIRE00030470

The Middle East & Africa PCR technologies market is expected to grow from US$ 626.35 million in 2022 to US$ 1,057.27 million by 2030. It is estimated to record a CAGR of 6.8% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Bolsters Middle East & Africa PCR Technologies Market

According to the National Organization's information on genetic conditions or congenital disabilities, genetic disorders are rare conditions, but they collectively comprise over 15,500 positive diagnoses every year. Estimates published in a report by MJH Life Sciences (US) in 2022 state that ~300,000 newborns are born with sickle cell disease (SCD) globally every year, accounting for ~5% of the global population. Further, as per the June 2020 report by Novartis AG, SCD affects around eight million individuals globally. Around 500 children die from SCD-related complications per day in Africa, where the disease has the highest burden. As a result of the rising incidence of SCDs, the adoption of digital polymerase chain reaction (dPCR) is increasing in pathology centers, wherein this technology is being exploited for targeting various DNA-specific sequences to confirm diagnoses and design various clinical tests. dPCR can target specific DNA sequences in just one molecule of DNA. This tool allows researchers to detect rare genetic mutations that are difficult to identify by using real-time PCR. The COVID-19 outbreak had a significant impact on the PCR technologies market. PCR is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations. The amplified DNA even serves as the basis for most next-generation sequencing (NGS) preparation. Nearly all diagnostic tests used real-time PCR for testing people having symptoms of COVID-19. Most of the biotech and pharmaceutical businesses shifted their focus toward research and development (R&D) divisions to find novel compounds or therapeutic approaches for COVID-19, which, in turn, benefitted the PCR technologies market. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These products include the Cobas SARS-CoV-2 and influenza A/B tests, as well as the Cobas SARS-CoV-2 qualitative test. The product offers uniform performance and efficiency in low-, medium-, and high-volume molecular laboratory tests. Thus, the increasing incidence of genetic and infectious diseases supports the growth of the PCR technologies market.

Middle East & Africa PCR Technologies Market Overview

The Middle East & Africa PCR technologies market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience significant growth due to an increase in the development of varied reagent systems and automated systems in this region, a wide range of new products in diagnostic laboratories, and a growing number of conferences, meetings, workshops, and symposiums. Saudi Arabia is among the fastest-growing countries in the Middle East & Africa. Changing healthcare infrastructure through public-private partnerships between government and international players strengthens the country's healthcare sector. These partnerships and privatization efforts align with the Saudi government's "Vision 2030" policies to transform the national economy. As per the International Trade Administration, the Saudi Arabian government invested ~US$ 65 billion to build the country's healthcare infrastructure as part of Vision 2030. Increased investment in infrastructure and innovation is anticipated to favor the market positively. PCR technologies have wide applications in the diagnosis of infectious diseases, oncology, autoimmune diseases, genetic diseases, HIV/AIDS, and others. It is used by medical practitioners in hospitals, laboratories, and other healthcare facilities and at various stages of the patient treatment process. Further, studies on DNA polymorphism, lung cancer, and colorectal cancer use dPCR and qPCR techniques to assess the mRNA expression of genes, boosting the PCR technologies market. Saudi Arabia has a growing number of genetic diseases due to consanguineous marriage, and thus, the increase in premarital genetic screening drives the market growth. The Government of Saudi Arabia has made it mandatory to undergo premarital genetic screening before marriage to check genetic compatibility to reduce hereditary blood diseases such as sickle cell and beta-thalassemia, which are most prevalent in the country. Therefore, the rising prevalence of genetic diseases and increasing premarital genetic testing in Saudi Arabia drive the market growth. Also, the growing number of cancer cases has fueled cancer research in Saudi Arabia. As per Globocan 2020 data, the country recorded ~27,885 new cancer cases. The five-year prevalence rate for cancer in all ages was found to be 237.4 per 100,000 people, which, in turn, propels the demand for PCR technologies in Saudi Arabia.

Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa PCR Technologies Market Segmentation

The Middle East & Africa PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Middle East & Africa PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Middle East & Africa PCR technologies market in 2022.

In terms of offerings, the Middle East & Africa PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Middle East & Africa PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

Based on application, the Middle East & Africa PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Middle East & Africa PCR technologies market in 2022.

Based on end user, the Middle East & Africa PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Middle East & Africa PCR technologies market in 2022.

By country, the Middle East & Africa PCR technologies market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd are some of the leading companies operating in the Middle East & Africa PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
    • 4.4.2 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Middle East & Africa Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Middle East & Africa PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa PCR Technologies Market -Country Analysis

  • 10.1 Middle East & Africa: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Middle East & Africa PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 Saudi Arabia
        • 10.1.2.1.1 Overview
      • 10.1.2.2 Saudi Arabia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 Saudi Arabia PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 Saudi Arabia PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 Saudi Arabia PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 Saudi Arabia PCR Technologies Market Breakdown by End User
      • 10.1.2.3 South Africa
        • 10.1.2.3.1 Overview
      • 10.1.2.4 South Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 South Africa PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 South Africa PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 South Africa PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 South Africa PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 South Africa PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 South Africa PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 South Africa PCR Technologies Market Breakdown by End User
      • 10.1.2.5 United Arab Emirates
        • 10.1.2.5.1 Overview
      • 10.1.2.6 United Arab
        • 10.1.2.6.1 United Arab Emirates PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 United Arab Emirates PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 United Arab Emirates PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 United Arab Emirates PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 United Arab Emirates PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 United Arab Emirates PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 United Arab Emirates PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Rest of Middle East & Africa
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Rest of Middle East & Africa PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Rest of Middle East & Africa PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Rest of Middle East & Africa PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Rest of Middle East & Africa PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Rest of Middle East & Africa PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Ellume Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 38. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 39. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Middle East & Africa: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Middle East & Africa PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. Saudi Arabia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. South Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. United Arab Emirates PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Rest of Middle East & Africa PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. Growth Strategies in the PCR Technologies Market